Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
7,942,180
-
Shares change
-
-44,908
-
Total reported value, excl. options
-
$113,685,116
-
Value change
-
-$1,235,865
-
Number of buys
-
16
-
Number of sells
-
-13
-
Price
-
$14.31
Significant Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q2 2019
36 filings reported holding TCRR - TCR2 THERAPEUTICS INC - COM as of Q2 2019.
TCR2 THERAPEUTICS INC - COM (TCRR) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,942,180 shares
.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (4,050,865 shares), Redmile Group, LLC (1,799,216 shares), Artal Group S.A. (490,000 shares), ArrowMark Colorado Holdings LLC (485,332 shares), HILLHOUSE CAPITAL MANAGEMENT, LTD. (322,903 shares), JPMORGAN CHASE & CO (192,337 shares), MILLENNIUM MANAGEMENT LLC (141,435 shares), AMERIPRISE FINANCIAL INC (120,600 shares), BlackRock Inc. (105,589 shares), and VANGUARD GROUP INC (74,779 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.